Stock OMND OPTIMIND PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Optimind Pharma Corp.

Equities

OMND

CA68405U1012

Market Closed - Canadian Securities Exchange
Other stock markets
 18:34:27 31/05/2024 BST 		5-day change 1st Jan Change
0.01 CAD -.--% Intraday chart for Optimind Pharma Corp. +100.00% +100.00%
01-26 Optimind Pharma Reaches Agreement On Debenture Conversion MT
01-10 Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Optimind Pharma Reaches Agreement On Debenture Conversion
Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023
Optimind Pharma Corp. Announces Executive Changes
Optimind Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023
Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions
Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended May 31, 2023
Optimind Pharma Corp. Auditor Raises 'Going Concern' Doubt
Optimind Pharma Corp. Reports Earnings Results for the Full Year Ended February 28, 2023
Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy
Optimind Pharma Corp. acquired MindSetting Inc. from Beatrice Society Inc. for CAD 1.6 million.
Optimind Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Optimind Pharma Corp. Provides Update on Health Canada's Dealer License Under Joint-Venture with Manitari Pharma Corporation
Reverse Split: 1 of 1.713084
FA
Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
Optimind Pharma Inc. completed the acquisition of Loon Energy Corporation (TSXV:LNE.H) in a reverse merger transaction.
Optimind Pharma Corp. announced that it has received CAD 0.507 million in funding
Optimind Pharma Inc. entered into a letter of intent to acquire Loon Energy Corporation (TSXV:LNE.H) for CAD 8.3 million in a reverse merger transaction.
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OMND Stock
  4. News Optimind Pharma Corp.
  5. Other languages